Cambridge Investment Research Advisors’s Innovator US Equity 10 Buffer ETF Quarterly ZALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$919K Sell
28,325
-1,915
-6% -$62.6K ﹤0.01% 2244
2025
Q4
$985K Buy
30,240
+8,377
+38% +$270K ﹤0.01% 2106
2025
Q3
$697K Buy
21,863
+2,572
+13% +$80.8K ﹤0.01% 2358
2025
Q2
$594K Sell
19,291
-313
-2% -$9.4K ﹤0.01% 2389
2025
Q1
$584K Buy
+19,604
New +$588K ﹤0.01% 2283

Other funds holding ZALT

Cambridge Investment Research Advisors's ZALT Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Innovator US Equity 10 Buffer ETF Quarterly (ZALT) stake by 6.3% in Q1 2026, selling an estimated $62.6K and leaving 28,325 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #2244.

Cambridge Investment Research Advisors first reported a position in ZALT in Q1 2025 and has held it in 5 quarters since. The position peaked at $985K in Q4 2025. 103 funds tracked by Wall St. Rank hold ZALT as of Q1 2026.

  • Cambridge Investment Research Advisors held 28,325 shares of Innovator US Equity 10 Buffer ETF Quarterly worth $919K as of Q1 2026.
  • Cambridge Investment Research Advisors sold 1,915 Innovator US Equity 10 Buffer ETF Quarterly shares in Q1 2026, an estimated $62.6K.
  • Innovator US Equity 10 Buffer ETF Quarterly made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #2244 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator US Equity 10 Buffer ETF Quarterly in Q1 2025 and has held it in 5 quarters since.
  • Cambridge Investment Research Advisors's Innovator US Equity 10 Buffer ETF Quarterly position peaked at $985K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Innovator US Equity 10 Buffer ETF Quarterly as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.